Literature DB >> 31436824

Cardiac mucormycosis: a case report.

Darshan Krishnappa1,2, Sanjeev Naganur1, Dinesh Palanisamy3, Ganesh Kasinadhuni1.   

Abstract

BACKGROUND: Mucormycosis is an invasive fungal infection (IFI) most commonly seen in immunocompromised patients. Diabetic ketoacidosis, haematopoietic transplantation, iron overload states, and deferoxamine therapy are considered to be some of the classical risk factors. While cutaneous and rhino-sinusoidal forms may be seen in immunocompetent (IC) individuals, cardiac and mediastinal involvement is rare. In this report, we describe a young patient without predisposing factors who presented as mediastinal mucormycosis with extensive cardiac involvement. CASE
SUMMARY: A 19-year-old male presented with complaints of dry cough and dyspnoea on exertion over the last 4 months. Echocardiography showed diffuse infiltration of both atria along with multiple pedunculated freely mobile masses. A computed tomography chest was done to further delineate the true extent of the disease and revealed diffuse infiltration of the mediastinum, bilateral atria and interatrial septum, pulmonary veins, and superior vena cava. A fine needle aspiration cytology from a mediastinal mass revealed broad aseptate fungal hyphae with right angled branching consistent with Mucor. Extensive evaluation could not find any predisposing factors. The patient was started on Amphotericin B and surgical debridement was contemplated. However, owing to the diffuse infiltration around the heart and mediastinal vasculature, debridement could not be performed and the patient eventually succumbed to the illness. DISCUSSION: Mediastinal mucormycosis though rare in IC patients, is a rapidly progressive condition with a high fatality. A high index of suspicion needs to be maintained in individuals presenting with infiltrative disorders of the mediastinum for early diagnosis and prompt treatment.
© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology.

Entities:  

Keywords:  Immunocompromise; Cardiac mucormycosis; Case report; Immunocompetent; Invasive fungal infection; Mediastinal mucormycosis

Year:  2019        PMID: 31436824      PMCID: PMC6764552          DOI: 10.1093/ehjcr/ytz130

Source DB:  PubMed          Journal:  Eur Heart J Case Rep        ISSN: 2514-2119


Learning points

In endemic geographical regions, invasive mucormycosis can occur even in individuals without predisposition. It has to be considered in the differential diagnosis of a infiltrating mass lesion involving heart and mediastinum. Invasive mucormycosis can present with imaging findings that can mimic sclerosing mediastinitis, other infiltrating fungal infections and neoplasms.

Introduction

Mucormycosis is an invasive fungal infection (IFI), usually seen in individuals with underlying predisposing conditions including diabetes mellitus, iron overload states and haematological malignancies. While rhino-sinusoidal and cutaneous forms may occur in all individuals, disseminated forms are usually seen in individuals with these risk factors. Isolated mediastinal involvement is rare and when it occurs usually presents as sclerosing mediastinitis. In this report, we describe a young patient without predisposing factors who presented with isolated mediastinal mucormycosis (MM) with predominant cardiac infiltration.

Case presentation

A 19-year-old gentleman presented to our centre with complaints of non-productive cough and dyspnoea on exertion for the past 4 months. Clinical examination was unremarkable while a chest X-ray was significant for a small right sided pleural effusion. Laboratory investigations showed neutrophilic leucocytosis, erythrocyte sedimentation rate (ESR) of 30 mm/h (0–20 mm/h) and fasting blood sugars within the normal range. A transthoracic echocardiogram was performed which showed a soft tissue mass with diffuse infiltration of the right and left atria along with multiple pedunculated masses attached to the lateral and superior wall of the left atrium (, Supplementary material online, Video S1 and S2). The mass was also seen to be infiltrating into the ostia of the superior pulmonary veins. On colour Doppler, he also had moderate tricuspid regurgitation with severe pulmonary hypertension.
Figure 1

(A) Transthoracic echocardiogram in parasternal short-axis view showing mass protruding (red arrow) and infiltrating all walls of left atrium (red arrow). (B) Apical four chamber view, showing diffuse infiltration of both atria, interatrial septum (red arrows), extending into the pulmonary vein ostium (blue arrow) with hanging mass in left atrium. (C) Parasternal long-axis view showing a pedunculated soft tissue mass in the left atrium (red arrow).

(A) Transthoracic echocardiogram in parasternal short-axis view showing mass protruding (red arrow) and infiltrating all walls of left atrium (red arrow). (B) Apical four chamber view, showing diffuse infiltration of both atria, interatrial septum (red arrows), extending into the pulmonary vein ostium (blue arrow) with hanging mass in left atrium. (C) Parasternal long-axis view showing a pedunculated soft tissue mass in the left atrium (red arrow). Computed tomography (CT) chest showed extensive mediastinal infiltration by a soft tissue mass, encasing both bronchi, superior vena cava, pulmonary veins and was seen extending into and enveloping the arch of the aorta (). The mass was also seen infiltrating the right atrium and extending through the interatrial septum into the left atrium ().
Figure 2

Computed tomography chest showing similar findings of (A) tissue infiltration in bilateral atria and interatrial septum (white arrow), (B) right and left pulmonary vein infiltration (blue arrows), and (C) superior venacava infiltration (white arrow).

Computed tomography chest showing similar findings of (A) tissue infiltration in bilateral atria and interatrial septum (white arrow), (B) right and left pulmonary vein infiltration (blue arrows), and (C) superior venacava infiltration (white arrow). The differential diagnosis considered included lymphoproliferative disorders and other primary cardiac tumours, IFI, sclerosing mediastinitis due to tuberculosis, histoplasmosis, aspergillosis, and clots. Fine needle aspiration cytology (FNAC) from the mediastinal mass showed broad, thin walled, aseptate fungal profiles with right angle branching consistent with Mucormycosis ().
Figure 3

PAS, periodic acid schiff (A, B) and MGG, May–Grunwald–Giemsa (C) stained images showing broad, aseptate, foldable fungal hyphae (red arrows) with right angled branching consistent with Mucor.

PAS, periodic acid schiff (A, B) and MGG, May–Grunwald–Giemsa (C) stained images showing broad, aseptate, foldable fungal hyphae (red arrows) with right angled branching consistent with Mucor. Blood cultures were sterile. He had no underlying risk factors like iron overload states, diabetes mellitus, intake of steroids, or other immunosuppressive drugs. There was no evidence of neutropenia, while the CD4 count was 670/µL. Serum galactomannan index was 0.63 and there was no histological evidence of aspergillosis. Nasal scrapings were negative for fungal hyphae. He was started on Amphotericin B and was initially considered for surgical debridement, which was later deferred in view of diffuse infiltration into and around the heart and great vessels. During the course of hospitalization, the patient developed right sided hemiparesis, facial palsy of the upper motor neuron type, and loss of vision in the left eye. A CT angiogram of the neck vessels showed occlusion of the left common carotid artery likely due to embolization. Pulmonary vein involvement led to pulmonary oedema with worsening respiratory failure and the patient eventually succumbed to the illness.

Discussion

Mucormycosis is one of the most common IFIs after candidiasis and aspergillosis in immunocompromised patients., Its rise in incidence parallels the rise in incidence of diabetes, cancer and need for organ transplantation. Classical risk factors include diabetes (with or without ketoacidosis), haematological malignancies, solid organ and bone marrow transplant recipients, deferoxamine therapy, intravenous drug use, and renal failure., However, occasionally it also occurs in the absence of risk factors. It is caused by angioinvasive moulds of the mucorales order. Inhalation of spores and cutaneous seeding at sites of epithelial breach are main portals of entry. It can manifest in various forms such as rhinocerebral, pulmonary, cutaneous, gastrointestinal, cerebral, and disseminated forms., Patients without any predisposition commonly present with cutaneous and rhino-sinusoidal involvement., Cardiac involvement in mucormycosis, although less common, can occur in invasive infections. It commonly occurs in patients with predisposing conditions or following cardiac surgery. It can present with a myriad of symptoms like myocardial infarction, new onset heart failure, endocarditis and valvular insufficiency, pericarditis, rhythm disturbances, or an abscess. In immunocompetent (IC) individuals, case reports of mucormycosis presenting as fibrosing mediastinitis with cardiac involvement and as mediastinal granuloma have been reported.,, Diagnosis needs high index of suspicion, especially in patients without predisposition and presentation other than rhinocerebral and cutaneous forms. Definitive diagnosis is made by tissue sampling and isolation of fungus or demonstration of typical broad, wide angled branching, aseptate hyphae with evidence of tissue invasion and necrosis. The standard therapy for mucormycosis is surgery along with Amphotericin B. Patients with invasive infection and cardiac involvement have a very poor prognosis with mortality up to 100%. Our index case described was a immunocompetent patient with mediastinal involvement (heart and great vessels) with angioinvasion (superior vena cava, pulmonary vein, and carotid involvement). Echocardiography demonstrated diffuse infiltration of both atria and provided the first clue to the presence of a systemic disease and CT imaging provided further insights. Definitive diagnosis was established by tissue sampling and demonstration of broad aseptate hyphae. Subsequently, the patient had a fulminant course during the hospital stay and died due to hypoxic respiratory failure (pulmonary vein invasion) and septic shock.

Conclusion

Mediastinal mucormycosis usually occurs as a disseminated form predominantly in individuals with predisposing factors. However, rarely it can occur in individuals without risk factors and should be considered in the differential diagnosis in all individuals presenting with infiltrating cardiac and mediastinal masses.

Lead author biography

Dr Ganesh Kasinadhuni, MD, DM is senior resident, cardiology at Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh. His area of interest is to excel in complex percutaneous coronary interventions. He started his academic and research under the able mentorship of Prof. Rajesh Vijayvergiya, Department of Cardiology at PGIMER. His future endeavour is to continue his academic research and publications. Click here for additional data file.
TimeEvents
4 months prior to presentationDry cough and dyspnoea on exertion which was gradually progressive and unattended.
Day 1Admitted at our centre for evaluation. Chest X-ray showed minimal right sided pleural effusion and echocardiography revealed soft tissue mass infiltrating bilateral atria.
Differentials considered in life time were lymphoma and other solid malignancies, clots, infiltrating fungal infections, primary cardiac neoplasms.
Day 3CECT chest was performed that showed mediastinal and cardiac infiltration, infiltration of superior venacava and pulmonary veins.
Day 5Clinical deterioration and worsening of breathlessness requiring oxygen support.
Day 6Computed tomography-guided fine needle aspiration was done from the mass lesion.
Day 7Smears confirmed to be Mucor hyphae. Prognosis explained to the patient family.
Day 8After extensive discussions with infectious disease team and surgical team, surgical debridement was deferred and was started on amphotericin.
Day 11Cardio embolic stroke and right sided hemiparesis and loss of vision in left eye.
Day 14Clinical condition worsened and finally succumbed to his illness.
  12 in total

Review 1.  A higher-level phylogenetic classification of the Fungi.

Authors:  David S Hibbett; Manfred Binder; Joseph F Bischoff; Meredith Blackwell; Paul F Cannon; Ove E Eriksson; Sabine Huhndorf; Timothy James; Paul M Kirk; Robert Lücking; H Thorsten Lumbsch; François Lutzoni; P Brandon Matheny; David J McLaughlin; Martha J Powell; Scott Redhead; Conrad L Schoch; Joseph W Spatafora; Joost A Stalpers; Rytas Vilgalys; M Catherine Aime; André Aptroot; Robert Bauer; Dominik Begerow; Gerald L Benny; Lisa A Castlebury; Pedro W Crous; Yu-Cheng Dai; Walter Gams; David M Geiser; Gareth W Griffith; Cécile Gueidan; David L Hawksworth; Geir Hestmark; Kentaro Hosaka; Richard A Humber; Kevin D Hyde; Joseph E Ironside; Urmas Kõljalg; Cletus P Kurtzman; Karl-Henrik Larsson; Robert Lichtwardt; Joyce Longcore; Jolanta Miadlikowska; Andrew Miller; Jean-Marc Moncalvo; Sharon Mozley-Standridge; Franz Oberwinkler; Erast Parmasto; Valérie Reeb; Jack D Rogers; Claude Roux; Leif Ryvarden; José Paulo Sampaio; Arthur Schüssler; Junta Sugiyama; R Greg Thorn; Leif Tibell; Wendy A Untereiner; Christopher Walker; Zheng Wang; Alex Weir; Michael Weiss; Merlin M White; Katarina Winka; Yi-Jian Yao; Ning Zhang
Journal:  Mycol Res       Date:  2007-03-13

2.  Acute myocardial infarction in disseminated mucormycosis infection.

Authors:  David Ferreira; Allan Davies; Thyaparan Thiruchelvam; Peter Wark
Journal:  Eur Heart J       Date:  2017-03-14       Impact factor: 29.983

Review 3.  Epidemiology and outcome of zygomycosis: a review of 929 reported cases.

Authors:  Maureen M Roden; Theoklis E Zaoutis; Wendy L Buchanan; Tena A Knudsen; Tatyana A Sarkisova; Robert L Schaufele; Michael Sein; Tin Sein; Christine C Chiou; Jaclyn H Chu; Dimitrios P Kontoyiannis; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2005-07-29       Impact factor: 9.079

4.  Mucor mediastinitis.

Authors:  B A Connor; R J Anderson; J W Smith
Journal:  Chest       Date:  1979-04       Impact factor: 9.410

Review 5.  Mucormycosis in immunocompetent patients: a case-series of patients with maxillary sinus involvement and a critical review of the literature.

Authors:  Michele D Mignogna; Giulio Fortuna; Stefania Leuci; Daniela Adamo; Elvira Ruoppo; Maria Siano; Umberto Mariani
Journal:  Int J Infect Dis       Date:  2011-07-20       Impact factor: 3.623

Review 6.  Zygomycosis: the re-emerging fungal infection.

Authors:  M Chayakulkeeree; M A Ghannoum; J R Perfect
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-04       Impact factor: 3.267

7.  Granulomatous mediastinitis due to rhizopus species.

Authors:  A S Leong
Journal:  Am J Clin Pathol       Date:  1978-07       Impact factor: 2.493

Review 8.  The clinical manifestations of cardiac mucormycosis.

Authors:  J D Jackman; R L Simonsen
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

9.  Cardiac mucormycosis. A report of five patients and review of 14 previously reported cases.

Authors:  R Virmani; D H Connor; H A McAllister
Journal:  Am J Clin Pathol       Date:  1982-07       Impact factor: 2.493

10.  Disseminated mucormycosis with myocardial involvement in a renal transplant recipient.

Authors:  Y Nam; J Jung; S S Park; S J Kim; S J Shin; J H Choi; M Kim; H E Yoon
Journal:  Transpl Infect Dis       Date:  2015-11-05       Impact factor: 2.228

View more
  3 in total

Review 1.  Mini Review: Risk Assessment, Clinical Manifestation, Prediction, and Prognosis of Mucormycosis: Implications for Pathogen- and Human-Derived Biomarkers.

Authors:  Jaime David Acosta-España; Kerstin Voigt
Journal:  Front Microbiol       Date:  2022-06-20       Impact factor: 6.064

Review 2.  Update on invasive fungal infections in the Middle Eastern and North African region.

Authors:  Marwan Osman; Aisha Al Bikai; Rayane Rafei; Hassan Mallat; Fouad Dabboussi; Monzer Hamze
Journal:  Braz J Microbiol       Date:  2020-07-05       Impact factor: 2.476

3.  Black fungus outbreak in India - A direct consequence of COVID-19 surge: A myth or reality.

Authors:  Archana Sharma; Megha Bedi; Prachi Patel; Amarpreet Singh Arora
Journal:  Gondwana Res       Date:  2022-02-05       Impact factor: 6.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.